Embolotherapy Business Research Report 2024-2030 Shift Toward Outpatient and Ambulatory Care Settings for Embolotherapy Procedures Expands Access and Drives Cost-Effective Healthcare Delivery
| STVZX Fund | USD 12.99 0.03 0.23% |
Slightly above 62% of Ridgeworth Ceredex's investor base is looking to short. The analysis of overall sentiment of trading Ridgeworth Ceredex Large mutual fund suggests that many investors are alarmed at this time. Ridgeworth Ceredex's investing sentiment can be driven by a variety of factors including economic data, Ridgeworth Ceredex's earnings reports, geopolitical events, and overall market trends.
Ridgeworth |
Embolotherapy Market Embolotherapy Market Dublin, Nov. 20, 2024 -- The Embolotherapy - Global Strategic Business Report report has been added to ResearchAndMarkets.coms offering.The global market for Embolotherapy was estimated at US5.1 Billion in 2023 and is projected to reach US8.5 Billion by 2030, growing at a CAGR of 7.5 percent from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed busines
Read at finance.yahoo.com
 |
Ridgeworth Ceredex Fundamental Analysis
We analyze Ridgeworth Ceredex's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Ridgeworth Ceredex using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Ridgeworth Ceredex based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Five Year Return
Five Year Return Comparative Analysis
Ridgeworth Ceredex is currently under evaluation in five year return among similar funds. Five Year Return is considered one of the best measures to evaluate fund performance, especially from the mid and long term perspective. It shows the total annualized return generated from holding equity for the last five years and represents capital appreciation of the investment, including all dividends, losses, and capital gains distributions.
Ridgeworth Ceredex Large Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Ridgeworth Ceredex mutual fund to make a market-neutral strategy. Peer analysis of Ridgeworth Ceredex could also be used in its relative valuation, which is a method of valuing Ridgeworth Ceredex by comparing valuation metrics with similar companies.
Peers
Ridgeworth Ceredex Related Equities
| TWQZX | Transamerica Large | 0.13 | ||||
| FIOOX | Fidelity Series | 0.06 | ||||
| TFCCX | Touchstone Large | 0.05 | ||||
| RCLIX | T Rowe | 0.31 | ||||
| LMISX | Qs Us | 0.50 | ||||
| LMUSX | Qs Us | 0.50 | ||||
| DLCIX | Dana Large | 0.77 |
Other Information on Investing in Ridgeworth Mutual Fund
Ridgeworth Ceredex financial ratios help investors to determine whether Ridgeworth Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Ridgeworth with respect to the benefits of owning Ridgeworth Ceredex security.
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |